Cargando…

Cost Analysis of Orthoptist-Led Neurofibromatosis Type 1 Screening Clinics

PURPOSE: To conduct a costing study comparing orthoptist-led with consultant-led clinics screening for optic pathway gliomas (OPGs) in children with neurofibromatosis Type 1 (NF1) attending the Royal Children’s Hospital (RCH), Melbourne. METHODS: Patients with NF1 examined in the orthoptist-led NF1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaur, Navdeep, Lewis, Catherine, Staffieri, Sandra, Ruddle, Jonathan, Goranitis, Ilias, Stiles, Jay, Dabscheck, Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	White Rose University Press 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103737/ https://www.ncbi.nlm.nih.gov/pubmed/37063611 http://dx.doi.org/10.22599/bioj.288

Ejemplares similares

The Role of the Orthoptist in the Treatment of Squint
por: Rankin, D. D.
Publicado: (1939)

What Do We Expect New Graduate Orthoptists to Do?
por: Horwood, Anna M.
Publicado: (2018)

The Impact of Preceptorship for Newly Graduated Orthoptists on Clinical Confidence and Attitudes towards Public Health
por: Farrelly-Waters, Martha, et al.
Publicado: (2022)

Utilising Virtual Clinics and Orthoptists to Aid COVID-19 Service Recovery in Adult Strabismus
por: Francis, Jessica E., et al.
Publicado: (2022)

Auditory Dysfunction Among Individuals With Neurofibromatosis Type 1
por: Rance, Gary, et al.
Publicado: (2021)

A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy
por: Catchpool, Max, et al.
Publicado: (2019)

Delineating the autistic phenotype in children with neurofibromatosis type 1
por: Chisholm, Anita K., et al.
Publicado: (2022)

A randomized controlled trial of remote microphone listening devices to treat auditory deficits in children with neurofibromatosis type 1
por: Rance, Gary, et al.
Publicado: (2022)

Development of a microcosting protocol to determine the economic cost of diagnostic genomic testing for rare diseases in Australia
por: Mordaunt, Dylan A, et al.
Publicado: (2023)

Health care financing and the sustainability of health systems
por: Liaropoulos, Lycourgos, et al.
Publicado: (2015)

Cost-Effectiveness of Targeted Exome Analysis as a Diagnostic Test in Glomerular Diseases
por: Jayasinghe, Kushani, et al.
Publicado: (2021)

MRI Screening for Optic Gliomas in Neurofibromatosis Type 1
por: Millichap, J. Gordon
Publicado: (2015)

Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study
por: Haebich, Kristina M, et al.
Publicado: (2019)

Hemostasis and Type 1 Neurofibromatosis
por: Niddam, Jeremy, et al.
Publicado: (2017)

Aerobic exercise for vasomotor menopausal symptoms: A cost-utility analysis based on the Active Women trial
por: Goranitis, Ilias, et al.
Publicado: (2017)

Neurofibromatosis-Associated Diffuse Lung Disease: A Case Report and Review of the Literature
por: Dehal, Navdeep, et al.
Publicado: (2020)

A Cost-Minimization Analysis of Nurse-Led Virtual Case Management in Late-Stage CKD
por: Ferguson, Thomas W., et al.
Publicado: (2020)

Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?
por: Santoro, Claudia, et al.
Publicado: (2018)

Prevalence of Endocrine Manifestations and GIST in 108 Systematically Screened Patients With Neurofibromatosis Type 1
por: Dupuis, Hippolyte, et al.
Publicado: (2023)

Validity and Responsiveness of Preference-Based Quality-of-Life Measures in Informal Carers: A Comparison of 5 Measures Across 4 Conditions
por: McLoughlin, Carol, et al.
Publicado: (2020)

Screening for mutation site on the type I neurofibromatosis gene in a family
por: Lv, Ming, et al.
Publicado: (2011)

Neurofibromatosis type 1
por: Mançano, Alexandre Dias
Publicado: (2022)

Cranio-orbital-temporal neurofibromatosis: An uncommon subtype of neurofibromatosis type-1
por: Acharya, Nibedita, et al.
Publicado: (2014)

Uptake of funded genomic testing for syndromic and non-syndromic intellectual disability in Australia
por: Mordaunt, Dylan A., et al.
Publicado: (2023)

Corneal endothelial cells and central corneal thickness in patients with neurofibromatosis type 1
por: Florou, Chrysoula, et al.
Publicado: (2021)

Neurofibromatosis
por: Gerber, PA, et al.
Publicado: (2009)

Neurofibromatosis
por: Hovinga, Koos E., et al.
Publicado: (2020)

The personal utility and uptake of genomic sequencing in pediatric and adult conditions: eliciting societal preferences with three discrete choice experiments
por: Goranitis, Ilias, et al.
Publicado: (2020)

Determining the utility of diagnostic genomics: a conceptual framework
por: Mallett, Andrew, et al.
Publicado: (2023)

Plexiform neurofibromatosis type 1
por: Sharma, Surendra K., et al.
Publicado: (2016)

Neurofibromatosis Type 1 in the Mandible
por: Uchiyama, Yuka, et al.
Publicado: (2018)

Antibiotic prophylaxis in the surgical management of miscarriage in low-income countries: a cost-effectiveness analysis of the AIMS trial
por: Goranitis, Ilias, et al.
Publicado: (2019)

Motor problems in children with neurofibromatosis type 1
por: Rietman, André B., et al.
Publicado: (2017)

Treatment, Resource Use and Costs Among Pediatric Patients with Neurofibromatosis Type 1 and Plexiform Neurofibromas
por: Yang, Xiaoqin, et al.
Publicado: (2020)

Neurofibromatosis 1: A family case series
por: Sethi, Neha K., et al.
Publicado: (2022)

Neurofibromatosis Type 1: Ocular Electrophysiological and Perimetric Anomalies
por: Nebbioso, Marcella, et al.
Publicado: (2020)

Neurofibromatosis in Children: Actually and Perspectives
por: Sur, Maria Lucia, et al.
Publicado: (2022)

Neurofibromatosis : revisión bibliográfica /
por: León Mendoza, Raúl
Publicado: (1987)

Neurofibromatosis Type 1: Review of Cutaneous and Subcutaneous Tumor Treatment on Quality of Life
por: Taylor, Lawrence A., et al.
Publicado: (2019)

Generalised Neurofibromatosis
por: Biggart, J. H.
Publicado: (1941)

Cannot write session to /tmp/vufind_sessions/sess_3ct5hd2juimorqjibp3uroq8nb